SARS-CoV-2, COVID-19 Rates Decreased After One Vaccine Dose
Study among health care workers shows reductions in SARS-CoV-2 infection rates one to 14, 15 to 28 days after first dose of the BNT162b2 COVID-19 vaccine
CDC Report Shows No Evidence of Unexpected Adverse Events With COVID-19 Vaccines
Findings from the first month show no unexpected adverse events, with 6,994 adverse events and >90 percent classified as nonserious
Water Problems Plague Texas Hospitals After Storm
Hospitals experiencing water pressure issues as well as widespread power outages
Pfizer to Begin Clinical Trial of COVID-19 Vaccine in Pregnant Women
Pfizer also planning to start trials of the vaccine in younger children, teens, people with weakened immune systems
U.S. to Provide $4 Billion for International COVID-19 Vaccine Program
U.N. Secretary-General Antonio Guterres says that 130 countries have not received a single dose of the vaccine
Factors Associated With Fracture Risk in Middle Age ID’d
Factors independently linked to incident fracture include age, sex, BMI, level of leisure-time physical activity
Pediatric Inpatient Admissions Down During Pandemic
Findings seen across a wide range of diagnoses and not reflective of seasonal variation
Physician’s Briefing Weekly Coronavirus Roundup
Age-Adjusted Suicide Rates Decreased From 2018 to 2019 in U.S.
2019 rates significantly lower in women aged 25 to 44 years and in boys and men aged 10 to 14, 45 to 64, and 65 to 74 years
Lenvatinib Plus Pembrolizumab Tops Sunitinib in Advanced RCC
Progression-free, overall survival significantly longer with combo versus sunitinib for advanced renal cell carcinoma
